These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30326113)

  • 21. FDA user fees approved.
    Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulatory review of novel therapeutics--comparison of three regulatory agencies.
    Downing NS; Aminawung JA; Shah ND; Braunstein JB; Krumholz HM; Ross JS
    N Engl J Med; 2012 Jun; 366(24):2284-93. PubMed ID: 22591257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M
    N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 27. User fees to hasten FDA review.
    Gershon D
    Nature; 1992 Oct; 359(6396):567. PubMed ID: 1406982
    [No Abstract]   [Full Text] [Related]  

  • 28. Whatever happened to user fees and the FDA's promise to expedite new drug approvals?
    Gatty B
    Hosp Formul; 1993 Jul; 28(7):656, 655. PubMed ID: 10127048
    [No Abstract]   [Full Text] [Related]  

  • 29. User fees for faster drug reviews. Are they helping or hurting the public health?
    Thompson L
    FDA Consum; 2000; 34(5):25-9. PubMed ID: 11590789
    [No Abstract]   [Full Text] [Related]  

  • 30. What ails the FDA?
    Okie S
    N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract]   [Full Text] [Related]  

  • 31. The prescription Drug User Fee Act of 1992 and the new drug development process.
    Kaitin KI
    Am J Ther; 1997; 4(5-6):167-72. PubMed ID: 10423607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New drug law to speed scientific review.
    Nature; 1992 Oct; 359(6396):563. PubMed ID: 1406977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences With and Challenges Afforded by Expedited Regulatory Pathways.
    Liu S; Kesselheim AS
    Clin Pharmacol Ther; 2019 Apr; 105(4):795-797. PubMed ID: 30883712
    [No Abstract]   [Full Text] [Related]  

  • 34. User fees to fund faster reviews.
    Henkel J
    FDA Consum; 1993 Oct; 27(8):19-21. PubMed ID: 10129049
    [No Abstract]   [Full Text] [Related]  

  • 35. Branded prescription drug fee. Final regulations, temporary regulations, and removal of temporary regulations.
    Internal Revenue Service (IRS), Treasury
    Fed Regist; 2014 Jul; 79(144):43631-45. PubMed ID: 25118373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. User fees hold up EU agency for drug approvals.
    Ward M
    Biotechnology (N Y); 1995 Mar; 13(3):213. PubMed ID: 9678939
    [No Abstract]   [Full Text] [Related]  

  • 37. The FDA's drug review process: ensuring drugs are safe and effective.
    Meadows M
    FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceuticals and the health of the public: use, safety, cost, access, ethics, and quality.
    Zito JM
    Med Care; 2012 Nov; 50(11):907-9. PubMed ID: 23047777
    [No Abstract]   [Full Text] [Related]  

  • 39. Vouchers for FDA priority reviews.
    Spatz ID
    Health Aff (Millwood); 2006; 25(4):1184; author reply 1184-5. PubMed ID: 16835203
    [No Abstract]   [Full Text] [Related]  

  • 40. Food and Drug Administration.
    Horton LR
    BMJ; 2007 Jan; 334(7584):55-6. PubMed ID: 17218671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.